• For Researchers

Making your research better: a patient perspective

Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways... Steve Clark tells us why patient involvement is so much more than just a requirement - it can actually bolster your research in surprising ways...

15 January 2026

• For Researchers

The switch and the Trojan horse: how viral vectors and synthetic enhancers could change glioblastoma treatment

Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic... Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic...

6 January 2026

• For Researchers

Spin doctors: taking on the challenge of tissue-specific cell cycle control

A false start, a Nobel Prize and renewed hope – understanding cell cycle disruption over different tissues is complex. But we are getting there…    A false start, a Nobel Prize and renewed hope – understanding cell cycle disruption over different tissues is complex. But we are getting there…   

27 November 2025

• For Researchers

Exploring the survival tactics of childhood cancers

Lava-dwelling lizards, cells playing dead and a century-old evolutionary theory – understanding the way childhood cancers resist treatment is proving to be quite a ride... Lava-dwelling lizards, cells playing dead and a century-old evolutionary theory – understanding the way childhood cancers resist treatment is proving to be quite a ride...

18 November 2025

• For Researchers

Getting to grips with the metastatic niche

Understanding how cancer spreads to distant parts of the body is a formidable challenge - but understanding it could be a real clinical breakthrough... Understanding how cancer spreads to distant parts of the body is a formidable challenge - but understanding it could be a real clinical breakthrough...

4 November 2025

• For Researchers

Animal instincts: Exploring nature’s oncologist

Can we pick apart how evolution has suppressed cancer in some species? Alex Cagen is attempting exactly that by going beyond mouse models… way beyond. Can we pick apart how evolution has suppressed cancer in some species? Alex Cagen is attempting exactly that by going beyond mouse models… way beyond.

27 October 2025

• For Researchers

Cancer – a disease of ageing… until it isn’t

Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that? Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that?

8 October 2025

• For Researchers

Piecing together the puzzle of cancer inequalities

The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle… The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle…

2 October 2025

• For Researchers

The challenges of going international for CYP

International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges… International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges…

24 September 2025

• For Researchers

A bridge for your career

Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme. Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme.

17 September 2025

• For Researchers

Level-up: Looking to epigenetics for the next immunotherapy breakthrough

Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted... Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted...

11 September 2025

• For Researchers

Is there a ribosomal weakness in cancer?

Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel... Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel...

9 July 2025